These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 38034007)

  • 21. From Gut to Glucose: A Comprehensive Review on Functional Foods and Dietary Interventions for Diabetes Management.
    Patel N; Dinesh S; Sharma S
    Curr Diabetes Rev; 2024; 20(5):e111023222081. PubMed ID: 37861021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study.
    Harbison JE; Roth-Schulze AJ; Giles LC; Tran CD; Ngui KM; Penno MA; Thomson RL; Wentworth JM; Colman PG; Craig ME; Morahan G; Papenfuss AT; Barry SC; Harrison LC; Couper JJ
    Pediatr Diabetes; 2019 Aug; 20(5):574-583. PubMed ID: 31081243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetes.
    Yuan X; Wang R; Han B; Sun C; Chen R; Wei H; Chen L; Du H; Li G; Yang Y; Chen X; Cui L; Xu Z; Fu J; Wu J; Gu W; Chen Z; Fang X; Yang H; Su Z; Wu J; Li Q; Zhang M; Zhou Y; Zhang L; Ji G; Luo F
    Nat Commun; 2022 Oct; 13(1):6356. PubMed ID: 36289225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The crucial role of early-life gut microbiota in the development of type 1 diabetes.
    Zhou H; Sun L; Zhang S; Zhao X; Gang X; Wang G
    Acta Diabetol; 2021 Mar; 58(3):249-265. PubMed ID: 32712802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of gut microbiome on type 1 diabetes susceptibility and complications: A large-scale bidirectional Mendelian randomization and external validation study.
    Guo K; Ye J; Li J; Huang J; Zhou Z
    Diabetes Obes Metab; 2024 Aug; 26(8):3306-3317. PubMed ID: 38751358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Prebiotic on Microbiota, Intestinal Permeability, and Glycemic Control in Children With Type 1 Diabetes.
    Ho J; Nicolucci AC; Virtanen H; Schick A; Meddings J; Reimer RA; Huang C
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4427-4440. PubMed ID: 31188437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Fecal Metabolite Signature of Impaired Fasting Glucose: Results From Two Independent Population-Based Cohorts.
    Nogal A; Tettamanzi F; Dong Q; Louca P; Visconti A; Christiansen C; Breuninger T; Linseisen J; Grallert H; Wawro N; Asnicar F; Wong K; Baleanu AF; Michelotti GA; Segata N; Falchi M; Peters A; Franks PW; Bagnardi V; Spector TD; Bell JT; Gieger C; Valdes AM; Menni C
    Diabetes; 2023 Dec; 72(12):1870-1880. PubMed ID: 37699401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota dysbiosis in Chinese children with type 1 diabetes mellitus: An observational study.
    Liu X; Cheng YW; Shao L; Sun SH; Wu J; Song QH; Zou HS; Ling ZX
    World J Gastroenterol; 2021 May; 27(19):2394-2414. PubMed ID: 34040330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding the Role of the Gut Microbiome in Diabetes and Therapeutics Targeting Leaky Gut: A Systematic Review.
    Sadagopan A; Mahmoud A; Begg M; Tarhuni M; Fotso M; Gonzalez NA; Sanivarapu RR; Osman U; Latha Kumar A; Mohammed L
    Cureus; 2023 Jul; 15(7):e41559. PubMed ID: 37554593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unique Gut Microbiome in HIV Patients on Antiretroviral Therapy (ART) Suggests Association with Chronic Inflammation.
    Ishizaka A; Koga M; Mizutani T; Parbie PK; Prawisuda D; Yusa N; Sedohara A; Kikuchi T; Ikeuchi K; Adachi E; Koibuchi T; Furukawa Y; Tojo A; Imoto S; Suzuki Y; Tsutsumi T; Kiyono H; Matano T; Yotsuyanagi H
    Microbiol Spectr; 2021 Sep; 9(1):e0070821. PubMed ID: 34378948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut dysbiosis, inflammation and type 2 diabetes in mice using synthetic gut microbiota from diabetic humans.
    Liaqat I; Ali NM; Arshad N; Sajjad S; Rashid F; Hanif U; Ara C; Ulfat M; Andleeb S; Awan UF; Bibi A; Mubin M; Ali S; Tahir HM; Ul-Haq I
    Braz J Biol; 2021; 83():e242818. PubMed ID: 34378656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms.
    Zhou H; Sun L; Zhang S; Zhao X; Gang X; Wang G
    Front Endocrinol (Lausanne); 2020; 11():125. PubMed ID: 32265832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice.
    Wu C; Pan LL; Niu W; Fang X; Liang W; Li J; Li H; Pan X; Chen W; Zhang H; Lakey JRT; Agerberth B; de Vos P; Sun J
    Front Immunol; 2019; 10():1733. PubMed ID: 31417546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gut microbiota in type 1 diabetes: friend or foe?
    Gavin PG; Hamilton-Williams EE
    Curr Opin Endocrinol Diabetes Obes; 2019 Aug; 26(4):207-212. PubMed ID: 31145129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut Microbiota Functional Traits, Blood pH, and Anti-GAD Antibodies Concur in the Clinical Characterization of T1D at Onset.
    Del Chierico F; Conta G; Matteoli MC; Fierabracci A; Reddel S; Macari G; Gardini S; Guarrasi V; Levi Mortera S; Marzano V; Vernocchi P; Sciubba F; Marini F; Deodati A; Rapini N; Cianfarani S; Miccheli A; Putignani L
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duodenal Mucosa of Patients With Type 1 Diabetes Shows Distinctive Inflammatory Profile and Microbiota.
    Pellegrini S; Sordi V; Bolla AM; Saita D; Ferrarese R; Canducci F; Clementi M; Invernizzi F; Mariani A; Bonfanti R; Barera G; Testoni PA; Doglioni C; Bosi E; Piemonti L
    J Clin Endocrinol Metab; 2017 May; 102(5):1468-1477. PubMed ID: 28324102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genistein prevention of hyperglycemia and improvement of glucose tolerance in adult non-obese diabetic mice are associated with alterations of gut microbiome and immune homeostasis.
    Huang G; Xu J; Lefever DE; Glenn TC; Nagy T; Guo TL
    Toxicol Appl Pharmacol; 2017 Oct; 332():138-148. PubMed ID: 28412308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disturbed sleep quality and architecture in adolescents with type 1 diabetes mellitus: Relation to glycemic control, vascular complications and insulin sensitivity.
    Abdelmaksoud AA; Salah NY; Ali ZM; Rashed HR; Abido AY
    Diabetes Res Clin Pract; 2021 Apr; 174():108774. PubMed ID: 33745994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes.
    Houghton D; Hardy T; Stewart C; Errington L; Day CP; Trenell MI; Avery L
    Diabetologia; 2018 Aug; 61(8):1700-1711. PubMed ID: 29754286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.
    Nicolucci A; Ceriello A; Di Bartolo P; Corcos A; Orsini Federici M
    Diabetes Ther; 2020 Mar; 11(3):573-584. PubMed ID: 31873857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.